GMPs Send Smaller Supplement Firms Into Contract Manufacturers’ Arms

FDA enforcement of the good manufacturing practices final rule causes some in the supplement industry to question whether small and medium-sized firms can manufacture in-house successfully. Meanwhile, third-party manufacturers are realizing the benefits of a tighter regulatory environment.

More from United States

More from North America